Home › Autoimmune Diseases › District of Columbia
Autoimmune Diseases clinical trials in District of Columbia
6 studies for Autoimmune Diseases are looking for participants at sites in District of Columbia.
Cities in District of Columbia
NIAID Centralized Sequencing Protocol
- Children's National Health System, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
1 Day – 100 Years · All sexes · Updated Oct 2, 2026 · NCT03206099Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1024, Washington D.C.
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's National Medical Center, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.